retatrutide 2025 trial results produces up to 30.3% weight loss in Phase 3 VisualAbstract: Retatrutide reduces body weight

More serious but less common adverse effects require clinical vigilance

Another source of VC-worthy revenue is supplements

Most of the trials were conducted in middle- and high-income countries, with little or no representation from regions such as Africa, Central America, and Southeast Asia

Cardio burns calories but doesn't protect muscle the way resistance training does

During dose escalation, when you are moving up to a new, higher dose, temporarily shifting your injection time to the evening (if you normally inject in the morning) can help you tolerate the transition

Dosing mistakes are the most common, and most preventable, problem in peptide research